TerryAJacobsonMD

Internal Medicine • Atlanta, GA

Healthcare Research and Healthcare Policy

Professor, Medicine, Emory University School of Medicine

Join to view full profile

Dr. Jacobson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jacobson's full profile

Already have an account?

Office
49 Jesse Hill Jr Dr SE
Emory Faculty Office Building
Atlanta, GA 30303
Phone+1 404-778-1625

Fax+1 404-778-1602
Is this information wrong?

Education & Training

NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1987
Weill Cornell MedicineClass of 1984

Certifications & Licensure

NY State Medical License 1985 - Present
GA State Medical License 1993 - 2025
PA State Medical License 1987 - 1998
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015

Publications & Presentations

PubMed

1 citations
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
Marlys L Koschinsky, Michael B Boffa, Dave L Dixon, Keith C Ferdinand, Edward A Gill, Michael J Wilkinson, Archna Bajaj, Samuel S Gidding, Terry A Jacobson, Erin D Mic...> ;Journal of Clinical Lipidology. 2024 Mar 29
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
Michael Szarek, Michael Miller, Jean-Claude Tardif, R Preston Mason, Steven B Ketchum, Armando Lira Pineda, Ralph T Doyle Jr, Ph Gabriel Steg, , Deepak L Bhatt, Eliot ...> ;Journal of the American College of Cardiology. 2024 Apr 23
2 citations
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
Neila Sayah, Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Lixia Jiao, Armando Lira Pineda, Ralph T Doyle Jr, Jean Claude Tardif...> ;European Heart Journal. 2024 Apr 1
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Gabriel Steg...> ;Journal of the American Heart Association. 2024 Jan 2
3 citations
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.
Michael Miller, Eliot A Brinton, Terry A Jacobson, Philippe Gabriel Steg, Armando Lira Pineda, Steven B Ketchum, Ralph T Doyle Jr, Jean-Claude Tardif, Bhatt, D., Balla...> ;European Heart Journal Open. 2023 Nov 1
4 citations
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
Brian Olshansky, Deepak L Bhatt, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle Jr, Rebecca A Juliano, Lixia Jiao,...> ;Journal of the American Heart Association. 2023 Mar 7
24 citations
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
Bruce A Warden, John R Guyton, Adrienne C Kovacs, Jessica A Durham, Laney K Jones, Dave L Dixon, Terry A Jacobson, P Barton Duell> ;Journal of Clinical Lipidology. 2022 Sep 11
136 citations
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal, Børge G Nordestgaard, Carl E Orringer> ;Journal of Clinical Lipidology. 2022 Aug 26
10 citations
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.
Michael Miller, Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, Christie M Ballantyne, Matthew Budoff, R Preston Mason> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2023 Feb 2
39 citations
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotei...
Paul M Ridker, Nader Rifai, Jean MacFadyen, Robert J Glynn, Lixia Jiao, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean-Claude Tardif, Christi...> ;Circulation. 2022 Aug 2
48 citations
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
Mary Katherine Cheeley, Joseph J Saseen, Anandita Agarwala, Sudha Ravilla, Nicole Ciffone, Terry A Jacobson, Dave L Dixon, Kevin C Maki> ;Journal of Clinical Lipidology. 2022 Jun 9
28 citations
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle Jr, C...> ;Journal of the American College of Cardiology. 2022 May 3
13 citations
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
Senthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Rebecca A Juliano, Lixia Jiao, Jean-Claude Tardif, Christie M Bal...> ;Journal of the American Heart Association. 2022 Apr 5
23 citations
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle...> ;Journal of the American Heart Association. 2022 Mar 15
8 citations
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Jordan B King, Brandon K Bellows, Gabriel S Tajeu, Catherine G Derin...> ;JAMA Network Open. 2022 Feb 1
13 citations
Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-IT.
Nickpreet Singh, Deepak L Bhatt, Michael Miller, Ph Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, R Preston Mason, Christie M Ballan...> ;Journal of the American College of Cardiology. 2022 Jan 18
28 citations
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Arjun Majithia, Deepak L. Bhatt, Allon N. Friedman, Michael Miller, Ph. Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia...> ;Circulation. 2021 Nov 30
28 citations
Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG
Subodh Verma, Deepak L. Bhatt, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Nitish K. Dhingra, Steven B. Ketchum, Rebecca A. Juliano, Lixia J...> ;Circulation. 2021 Oct 28
22 citations
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Prakriti Gaba, Deepak L. Bhatt, Robert P. Giugliano, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixi...> ;Journal of the American College of Cardiology. 2021 Oct 12
46 citations
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
Peter W.F. Wilson, Terry A. Jacobson, Seth S. Martin, Elizabeth A. Jackson, N-Anh Le, Michael H. Davidson, Hubert W. Vesper, Ruth Frikke-Schmidt, Christie M. Ballantyn...> ;Journal of Clinical Lipidology. 2021 Sep 24
7 citations
Dyslipidemia in Patients with Kidney Disease.
Aneesha Thobani, Terry A. Jacobson> ;Cardiology Clinics. 2021 Aug 1
15 citations
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results.
Brian Olshansky, Deepak L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia J...> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2021 May 23
34 citations
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Benjamin E Peterson, Deepak L. Bhatt, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T...> ;Circulation. 2021 Jan 5
88 citations
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction.
Carl E. Orringer, Michael J. Blaha, Ron Blankstein, Matthew J. Budoff, Ronald B. Goldberg, Edward A. Gill, Kevin C. Maki, Laxmi S. Mehta, Terry A. Jacobson> ;Journal of Clinical Lipidology. 2021 Jan 1
60 citations
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
Emily E. Brown, Amy C. Sturm, Marina Cuchel, Lynne T. Braun, P. Barton Duell, James A. Underberg, Terry A. Jacobson, Robert A. Hegele> ;Journal of Clinical Lipidology. 2020 Jul 1
Join now to see all

Journal Articles

Safety and Efficacy of Statin Therapy
Bhavin B Adhyaru, Terry A Jacobson, Nature

Press Mentions

National Lipid Association Releases Official Scientific Statement Regarding Use of Lipoprotein(A) in Clinical PracticeMay 17th, 2019
American Heart Association Says Fish Oil Supplements May Help Prevent Death After a Heart Attack but Lack Evidence of Cardiovascular Benefit for the General PopulationMarch 14th, 2017